Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Paediatric therapeutic development workshop on medulloblastoma.

British journal of cancer·2026

Same author

Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

British journal of cancer·2026

Same author

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Cancers·2026

Same author

Dominant clones leverage developmental epigenomic states to drive ependymoma.

Nature·2026

Same author

Proteasome Cap Targeting Chimeras for Ubiquitination-Independent Targeted Protein Degradation.

Angewandte Chemie (International ed. in English)·2026

Same author

Cell state plasticity in neuroblastoma.

EJC paediatric oncology·2025

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Lineage-Selective Dependencies in Pediatric Cancers.

K Elaine Ritter¹, Adam D Durbin²

¹Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38015, USA.

Cold Spring Harbor Perspectives in Medicine

|May 28, 2024

Summary

Researchers are identifying new cancer drug targets by looking at genetic dependencies, especially in pediatric cancers. These lineage-selective dependencies offer a promising therapeutic window for difficult-to-treat tumors.

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 25, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Area of Science:

Oncology
Genetics
Molecular Biology

Background:

Traditional cancer therapeutics target mutated oncogenic proteins, facing challenges in low-mutation cancers like pediatric tumors.
Unbiased genetic screens are crucial for identifying novel therapeutic targets when conventional approaches fail.

Purpose of the Study:

To discuss the identification of lineage-selective dependency genes as potential therapeutic targets.
To explore how transcriptional network models can elucidate the role of these dependencies in pediatric cancers.

Main Methods:

Utilizing large-scale unbiased genetic screens to discover collateral dependencies in cancer cells.
Analyzing lineage-selective dependencies within the context of transcriptional network models.

Main Results:

Identification of lineage-selective dependency genes, offering a potential therapeutic window.
Demonstration that these dependencies are often linked to gene expression and tumor developmental origins.

Conclusions:

Lineage-selective dependencies represent promising targets for pediatric cancer therapeutics.
Transcriptional network models, including core regulatory circuits and gene regulatory networks, provide frameworks for understanding these dependencies.